Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

A local lymph node assay performed with female CBA mice showed that 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline does not possess skin sensitizing properties, so that no classification of the substance for this endpoint is required. No information has been reported about the potential of 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline to induce respiratory sensitization. However, the inhalation route of exposure is considered as not relevant for the identified use of the substance.


Migrated from Short description of key information:
The skin sensitisation potential of 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline using the murine local lymph node assay (LLNA) was assessed in compliance with OECD Guideline for Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay" (Bull 2008b).

Respiratory sensitisation

Endpoint conclusion
Additional information:
Migrated from Short description of key information:
Not applicable.

Justification for classification or non-classification

Based on the sensitization rate which is below the threshold of significance (i.e. below 30%) set in Commission Directive 93/21/EEC (18th adaptation to technical progress of Council Directive 67/548/EEC), classification of 3,3'-[biphenyl-4,4'-diylbis(oxy)]dianiline as to its sensitising properties is not required.